Abstract Categories

Deadline for Abstract Submission : by March 31, 2020
Extended : by April 8, 2021




• Leukemia, Myelodysplasia, and Transplantation • Metabolism and Cancer
• Lymphoma and Plasma Cell Disorders • Oncogenomics 
• Head and Neck Cancer • Bioinformatics and Computational Molecular Biology
• Lung Cancer • Innovative Technologies in Cancer Research
• Gastrointestinal (Colorectal) Cancer • microRNAs and Other Noncoding RNAs
• Anal Cancer • Cancer Systems Biology
• Colorectal Cancer • Cellular Stress Responses
• Small Bowel Cancer • Cell Culture and Animal Models of Cancer
• Gastrointestinal (Noncolorectal) Cancer • Stem Cell Biology/Cancer Stem Cells/Developmental Oncobiology
• Esophageal or Gastric Cancer • Tumor Adhesion
• Hepatobiliary Cancer • Tumor Invasion and metastasis
• Pancreatic Cancer • Angiogenesis, Vasculogenesis, Microcirculation, and Cellular Microenvironment
• Neuroendocrine/Carcinoid • Tumor Microenvironment
• Other GI Cancer • In Vivo Imaging
• Breast Cancer • Radiation Biology
• Genitourinary Cancer • Carcinogenesis - Chemical, Viral, and Radiation
• Gynecologic Cancer • Drug Discovery and Design
• Sarcoma • Structural and Chemical Biology
• Neuroendocrine tumor • Proteomics, Metabolomics, and Biological Mass Spectrometry
• Melanoma/Skin Cancers • Chemical Aspects of Carcinogenesis
• Radiation Oncology • Imaging Agents and Radiotherapeutics
• Geriatric Oncology • Drug Delivery
• Pediatric Oncology • Translational Research Molecular Biology in the Clinic
• Supportive Care and Survivorship Research • Biostatistics in Clinical Trials
• Developmental Therapeutics • Molecular Biomarkers for Diagnosis, Prognosis, and Prediction
• Patient and Survivor Care • Clinical Immunology/Biological Therapy
• Cancer Prevention/Epidemiology • Experimental and Molecular Therapeutics
• Clinical Trials • Regulatory Science and Policy
• Ethics in Clinical Trials • New Molecular Targets
• Health Services Research • Mechanisms of Drug Action
• Cell Growth Signaling Pathways • Pharmacology, Pharmacogenetics, and Pharmacogenomics
• Cell Death • Drug Resistance
• Molecular Genetics • Biological Therapeutic Agents
• Oncogenes and Tumor Suppressor Genes • Small Molecule Therapeutic Agents
• Gene Regulation and Transcription Factors • Tumor Immunobiology
• Epigenetics • Gene and Vector-Based Therapy
• Cell Cycle • Prevention Research
• DNA Damage and Repair • Cancer Immunotherapy, Preclinical and Clinical